Lv62
2540 积分 2022-03-30 加入
Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 Study
1小时前
已完结
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
5天前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
5天前
已完结
Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study
5天前
已完结
Tackling Osimertinib Resistance in EGFR-Mutant Non–Small Cell Lung Cancer
20天前
已完结
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration
24天前
已完结
Clinical utility of NGS diagnosis and disease stratification in a multiethnic primary ciliary dyskinesia cohort
24天前
已关闭
Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
24天前
已完结
A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC
26天前
已完结
DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
1个月前
已完结
皖公网安备34019202002308
